PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
15233086-3	2004	Raman spectroscopy indicates that color changes associated with tub unrolling can be attributed to V2O5 formation.	vanadium pentoxide	99-103	TUB bipartite transcription factor	Homo sapiens	64-67
14556849-3	2003	We investigated the mechanisms through which vanadium pentoxide (V2O5), the major form of vanadium released from the industrial burning of fuel oil, activated the signal transducer and activator of transcription (STAT)-1.	vanadium pentoxide	45-63	signal transducer and activator of transcription 1	Rattus norvegicus	163-220
14556849-3	2003	We investigated the mechanisms through which vanadium pentoxide (V2O5), the major form of vanadium released from the industrial burning of fuel oil, activated the signal transducer and activator of transcription (STAT)-1.	vanadium pentoxide	65-69	signal transducer and activator of transcription 1	Rattus norvegicus	163-220
14556849-7	2003	V2O5 suppressed H2O2 for as long as 24 h. Differences in the temporal activation of STAT-1 and p38 MAPK were observed following V2O5 or H2O2 treatment, and STAT-1 activation by V2O5 or H2O2 was attenuated by an inhibitor of the EGF receptor tyrosine kinase (AG1478) or p38 MAPK (SB203580).	vanadium pentoxide	128-132	signal transducer and activator of transcription 1	Rattus norvegicus	84-90
14556849-7	2003	V2O5 suppressed H2O2 for as long as 24 h. Differences in the temporal activation of STAT-1 and p38 MAPK were observed following V2O5 or H2O2 treatment, and STAT-1 activation by V2O5 or H2O2 was attenuated by an inhibitor of the EGF receptor tyrosine kinase (AG1478) or p38 MAPK (SB203580).	vanadium pentoxide	0-4	signal transducer and activator of transcription 1	Rattus norvegicus	84-90
14556849-7	2003	V2O5 suppressed H2O2 for as long as 24 h. Differences in the temporal activation of STAT-1 and p38 MAPK were observed following V2O5 or H2O2 treatment, and STAT-1 activation by V2O5 or H2O2 was attenuated by an inhibitor of the EGF receptor tyrosine kinase (AG1478) or p38 MAPK (SB203580).	vanadium pentoxide	0-4	mitogen activated protein kinase 14	Rattus norvegicus	95-98
14556849-7	2003	V2O5 suppressed H2O2 for as long as 24 h. Differences in the temporal activation of STAT-1 and p38 MAPK were observed following V2O5 or H2O2 treatment, and STAT-1 activation by V2O5 or H2O2 was attenuated by an inhibitor of the EGF receptor tyrosine kinase (AG1478) or p38 MAPK (SB203580).	vanadium pentoxide	128-132	mitogen activated protein kinase 14	Rattus norvegicus	95-98
14556849-7	2003	V2O5 suppressed H2O2 for as long as 24 h. Differences in the temporal activation of STAT-1 and p38 MAPK were observed following V2O5 or H2O2 treatment, and STAT-1 activation by V2O5 or H2O2 was attenuated by an inhibitor of the EGF receptor tyrosine kinase (AG1478) or p38 MAPK (SB203580).	vanadium pentoxide	0-4	signal transducer and activator of transcription 1	Rattus norvegicus	156-162
14556849-7	2003	V2O5 suppressed H2O2 for as long as 24 h. Differences in the temporal activation of STAT-1 and p38 MAPK were observed following V2O5 or H2O2 treatment, and STAT-1 activation by V2O5 or H2O2 was attenuated by an inhibitor of the EGF receptor tyrosine kinase (AG1478) or p38 MAPK (SB203580).	vanadium pentoxide	128-132	mitogen activated protein kinase 14	Rattus norvegicus	269-272
14556849-7	2003	V2O5 suppressed H2O2 for as long as 24 h. Differences in the temporal activation of STAT-1 and p38 MAPK were observed following V2O5 or H2O2 treatment, and STAT-1 activation by V2O5 or H2O2 was attenuated by an inhibitor of the EGF receptor tyrosine kinase (AG1478) or p38 MAPK (SB203580).	vanadium pentoxide	0-4	mitogen activated protein kinase 14	Rattus norvegicus	269-272
14556849-8	2003	The phosphorylation of p38 MAPK by V2O5 was inhibited by NAC and catalase, yet the EGF receptor inhibitor AG1478 had no effect on V2O5-induced p38 MAPK activation.	vanadium pentoxide	35-39	mitogen activated protein kinase 14	Rattus norvegicus	23-26
12376484-4	2002	Vanadium pentoxide-induced mouse lung carcinomas, which had been shown to have a high frequency of K-ras mutations and LOH on chromosome 6 and for which frozen tumor tissue was available, were used for this study.	vanadium pentoxide	0-18	Kirsten rat sarcoma viral oncogene homolog	Mus musculus	99-104
14556849-8	2003	The phosphorylation of p38 MAPK by V2O5 was inhibited by NAC and catalase, yet the EGF receptor inhibitor AG1478 had no effect on V2O5-induced p38 MAPK activation.	vanadium pentoxide	35-39	catalase	Rattus norvegicus	65-73
12676768-5	2003	Exogenous H(2)O(2) (>10 microM) mimicked the effect of V(2)O(5) in upregulating HB-EGF expression.	vanadium pentoxide	58-66	heparin binding EGF like growth factor	Homo sapiens	83-89
12376484-11	2002	These results suggest that MAPK is activated during vanadium pentoxide-induced B6C3F1 mouse lung tumorigenesis following K-ras mutation and loss of the wild-type K-ras allele.	vanadium pentoxide	52-70	Kirsten rat sarcoma viral oncogene homolog	Mus musculus	121-126
12376484-11	2002	These results suggest that MAPK is activated during vanadium pentoxide-induced B6C3F1 mouse lung tumorigenesis following K-ras mutation and loss of the wild-type K-ras allele.	vanadium pentoxide	52-70	Kirsten rat sarcoma viral oncogene homolog	Mus musculus	162-167
9458803-8	1998	Supernatants from alveolar macrophages treated with V2O5 in vitro released upregulatory activity for PDGF-R alpha on cultured lung myofibroblasts, and this activity was blocked by the interleukin-1-receptor antagonist.	vanadium pentoxide	52-56	platelet derived growth factor receptor alpha	Rattus norvegicus	101-113
11159045-6	2001	Vanadium pentoxide (V2O5), a fibrogenic metal associated with occupational asthma, caused a several-fold increase in HB-EGF mRNA expression and protein, whereas the inert metal titanium dioxide had no effect on HB-EGF expression.	vanadium pentoxide	0-18	heparin binding EGF like growth factor	Homo sapiens	117-123
11159045-6	2001	Vanadium pentoxide (V2O5), a fibrogenic metal associated with occupational asthma, caused a several-fold increase in HB-EGF mRNA expression and protein, whereas the inert metal titanium dioxide had no effect on HB-EGF expression.	vanadium pentoxide	20-24	heparin binding EGF like growth factor	Homo sapiens	117-123
11159045-7	2001	V2O5-induced HB-EGF mRNA expression was inhibited by the EGF-R tyrosine kinase inhibitor AG1478, the p38 mitogen-activated protein (MAP) kinase inhibitor SB203580, and the MAP kinase kinase inhibitor PD98059.	vanadium pentoxide	0-4	heparin binding EGF like growth factor	Homo sapiens	13-19
11159045-7	2001	V2O5-induced HB-EGF mRNA expression was inhibited by the EGF-R tyrosine kinase inhibitor AG1478, the p38 mitogen-activated protein (MAP) kinase inhibitor SB203580, and the MAP kinase kinase inhibitor PD98059.	vanadium pentoxide	0-4	epidermal growth factor receptor	Homo sapiens	57-62
10783131-0	2000	Mechanism of extracellular signal-regulated kinase (ERK)-1 and ERK-2 activation by vanadium pentoxide in rat pulmonary myofibroblasts.	vanadium pentoxide	83-101	mitogen activated protein kinase 3	Rattus norvegicus	13-58
10783131-0	2000	Mechanism of extracellular signal-regulated kinase (ERK)-1 and ERK-2 activation by vanadium pentoxide in rat pulmonary myofibroblasts.	vanadium pentoxide	83-101	mitogen activated protein kinase 1	Rattus norvegicus	63-68
34661622-8	2021	V2O5 nanoflakes significantly reduced mRNA and protein alphaSMA concentrations in the presence of TGF-beta1.	vanadium pentoxide	0-4	actin alpha 1, skeletal muscle	Homo sapiens	55-63
7737603-2	1995	Proliferin transcripts were induced 40- to 100-fold by 20 microM ammonium metavanadate, 20-fold by 5 microM vanadium pentoxide but only three-fold by vanadium oxide sulfate.	vanadium pentoxide	108-126	prolactin family 2, subfamily c, member 2	Mus musculus	0-10
34537646-1	2022	In this study, spinel CuCo2O4 (CCO) with a hierarchical hollow sphere morphology was encapsulated in V2O5-decorated ultra-wrinkled graphitic carbon-nitride (VO-UCN) for the first time via a facile glycerol-assisted solvothermal method in the interest of developing a novel high-efficiency double Z-type nano-photocatalyst (denoted as VO-UCN@CCO).	vanadium pentoxide	101-105	urocortin	Homo sapiens	160-163
34537646-1	2022	In this study, spinel CuCo2O4 (CCO) with a hierarchical hollow sphere morphology was encapsulated in V2O5-decorated ultra-wrinkled graphitic carbon-nitride (VO-UCN) for the first time via a facile glycerol-assisted solvothermal method in the interest of developing a novel high-efficiency double Z-type nano-photocatalyst (denoted as VO-UCN@CCO).	vanadium pentoxide	101-105	urocortin	Homo sapiens	337-340
34958226-0	2022	From Microurchins to V2O5 Nanowalls: Improved Synthesis through Vanadium Powder and Fast, Selective Adsorption of Methylene Blue.	vanadium pentoxide	21-25	Fas activated serine/threonine kinase	Homo sapiens	84-88
34913685-6	2021	Post-RTA conformal V2O5 deposition yielded pseudocapacitors with 10-fold increase in energy density (20 muW h cm-2 mum-1) without adversely affecting the high power density (450 muW cm-2 mum-1).	vanadium pentoxide	19-23	PWWP domain containing 3A, DNA repair factor	Homo sapiens	115-120
34913685-6	2021	Post-RTA conformal V2O5 deposition yielded pseudocapacitors with 10-fold increase in energy density (20 muW h cm-2 mum-1) without adversely affecting the high power density (450 muW cm-2 mum-1).	vanadium pentoxide	19-23	PWWP domain containing 3A, DNA repair factor	Homo sapiens	187-192
34471719-5	2021	This work aimed to determine pyramidal hippocampal CA1 cytoskeletal alterations with Bielschowsky stain in rats exposed to V2O5.	vanadium pentoxide	123-127	carbonic anhydrase 1	Rattus norvegicus	51-54
34403678-5	2021	The emerged V2O5@Ch/Cu-TMA is regarded as an excellent nanobiosorbent for removal of inorganic contaminant as Cr(VI) from all natural water samples (tap, sea and wastewater) with percentages range 92.43%-96.95% and organic contaminant as LEVO drug from tap and wastewater (91.99%-97.20%).	vanadium pentoxide	12-16	nuclear RNA export factor 1	Homo sapiens	149-152
34403678-5	2021	The emerged V2O5@Ch/Cu-TMA is regarded as an excellent nanobiosorbent for removal of inorganic contaminant as Cr(VI) from all natural water samples (tap, sea and wastewater) with percentages range 92.43%-96.95% and organic contaminant as LEVO drug from tap and wastewater (91.99%-97.20%).	vanadium pentoxide	12-16	nuclear RNA export factor 1	Homo sapiens	253-256
34318777-8	2021	The HRi composite presented a distinctive composition compared to other materials and was the only composite that showed a smaller percentage of SiO2, and also was the only composite that contained compounds, such as P2O5, ZnO, CaO, La2O3, and V2O5.	vanadium pentoxide	244-248	eukaryotic translation initiation factor 2 alpha kinase 1	Homo sapiens	4-7
32407624-7	2020	In contrast, upon 1000 mumol Na+ g-1 treatment, severe alkali deactivation occurred for a commercial V2O5/WO3-TiO2.	vanadium pentoxide	101-105	growth differentiation factor 15	Homo sapiens	29-36
216760-1	1978	Inhibition of adenosinetriphosphatase (ATPase) by vanadium pentoxide (dissolved in water or in sodium hydroxide solution) was studied in microsomal fractions and tissue homogenates of kidney, brain, and heart of several species, including humans (kidney only).	vanadium pentoxide	50-68	ATPase Na+/K+ transporting subunit beta 1	Homo sapiens	14-37
216760-1	1978	Inhibition of adenosinetriphosphatase (ATPase) by vanadium pentoxide (dissolved in water or in sodium hydroxide solution) was studied in microsomal fractions and tissue homogenates of kidney, brain, and heart of several species, including humans (kidney only).	vanadium pentoxide	50-68	ATPase Na+/K+ transporting subunit beta 1	Homo sapiens	39-45
35522460-3	2022	Herein, a representative MOF, MIL-125-NH2, is integrated with metal oxides (MoO3 and V2O5) that feature appropriate work function and energy level to afford the corresponding MOF composites.	vanadium pentoxide	85-89	lysine acetyltransferase 8	Homo sapiens	25-28
35522460-3	2022	Herein, a representative MOF, MIL-125-NH2, is integrated with metal oxides (MoO3 and V2O5) that feature appropriate work function and energy level to afford the corresponding MOF composites.	vanadium pentoxide	85-89	lysine acetyltransferase 8	Homo sapiens	175-178
35404044-0	2022	Insight into the Transformation Behaviors of Dioxins from Sintering Flue Gas in the Cyclic Thermal Regeneration by the V2O5/AC Catalyst-sorbent.	vanadium pentoxide	119-123	gastrin	Homo sapiens	73-76
3686536-4	1987	The less soluble form of vanadium (vanadium pentoxide) was eliminated from the lungs at a slow but exponentially linear rate, whereas the soluble form was translocated rapidly from this organ and exhibited a non-linear decline.	vanadium pentoxide	35-53	cytotoxic T-lymphocyte-associated protein 4	Rattus norvegicus	9-21
2885397-8	1987	Vanadium pentoxide inhibited phosphorylation of CAP2 but had a minimal effect on pp50.	vanadium pentoxide	0-18	cyclase associated actin cytoskeleton regulatory protein 2	Bos taurus	48-52
32510918-0	2020	CdS Quantum-Dots-Decorated V2O5 Nanosheets as Chemically Etchable Active Materials for Sensitive Photoelectrochemical Immunoassay of Carcinoembryonic Antigen.	vanadium pentoxide	27-31	CEA cell adhesion molecule 3	Homo sapiens	133-157
32510918-4	2020	Inspired by this phenomenon, a PEC immunoassay platform is constructed for carcinoembryonic antigen (CEA) detection by using CdS/V2O5 nanocomposite as the photoelectric material and AA-encapsulated liposome immunonanocapsules as labels.	vanadium pentoxide	129-133	CEA cell adhesion molecule 3	Homo sapiens	75-99
32510918-4	2020	Inspired by this phenomenon, a PEC immunoassay platform is constructed for carcinoembryonic antigen (CEA) detection by using CdS/V2O5 nanocomposite as the photoelectric material and AA-encapsulated liposome immunonanocapsules as labels.	vanadium pentoxide	129-133	CEA cell adhesion molecule 3	Homo sapiens	101-104
30965001-1	2019	A high-performance, low-cost, aqueous Al-ion supercapacitor was fabricated based on nanostructured V2O5 impregnated mesoporous carbon microspheres (MCM/V2O5) electrodes and Al2(SO4)3 electrolyte for efficient energy storage.	vanadium pentoxide	99-103	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha	Homo sapiens	148-151
32040104-4	2020	In this work, we construct a V-MOF (MIL-47) derived V2O3@C hollow microcuboid with a hierarchical lasagna-like structure through hydrothermal synthesis followed by calcination, and employ it as a sulfur host for the first time.	vanadium pentoxide	52-56	lysine acetyltransferase 8	Homo sapiens	31-34
31627810-0	2019	Nitrogen-doped carbon dots-V2O5 nanobelts sensing platform for sensitive detection of ascorbic acid and alkaline phosphatase activity.	vanadium pentoxide	27-31	alkaline phosphatase, placental	Homo sapiens	104-124
31180199-6	2019	The optimized coating layer, vanadium oxy-acetylacetonate (VO(acac)2), plays an important role to generate a more inorganic component (LiF) within the solid electrolyte interface, contributing to the protection of the Ca-incorporated V2O5 electrode.	vanadium pentoxide	234-238	LIF interleukin 6 family cytokine	Homo sapiens	135-138
31094519-3	2019	Both CO2 and COCl2 are products of CCl4 reaction on a bulk vanadium oxide surface, while chloride (or chlorine) transfer is not observed.	vanadium pentoxide	59-73	C-C motif chemokine ligand 4	Homo sapiens	35-39
30965001-2	2019	MCM/V2O5 composites exhibit high dispersion of nanostructured V2O5 in a mesoporous carbon matrix, beneficial to fast reversible redox reactions with a short diffusion path.	vanadium pentoxide	4-8	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha	Homo sapiens	0-3
29228829-0	2018	Vanadium pentoxide increased PTEN and decreased SHP1 expression in NK-92MI cells, affecting PI3K-AKT-mTOR and Ras-MAPK pathways.	vanadium pentoxide	0-18	phosphatase and tensin homolog	Homo sapiens	29-33
29228829-0	2018	Vanadium pentoxide increased PTEN and decreased SHP1 expression in NK-92MI cells, affecting PI3K-AKT-mTOR and Ras-MAPK pathways.	vanadium pentoxide	0-18	nuclear receptor subfamily 0 group B member 2	Homo sapiens	48-52
29228829-0	2018	Vanadium pentoxide increased PTEN and decreased SHP1 expression in NK-92MI cells, affecting PI3K-AKT-mTOR and Ras-MAPK pathways.	vanadium pentoxide	0-18	AKT serine/threonine kinase 1	Homo sapiens	97-100
29228829-0	2018	Vanadium pentoxide increased PTEN and decreased SHP1 expression in NK-92MI cells, affecting PI3K-AKT-mTOR and Ras-MAPK pathways.	vanadium pentoxide	0-18	mechanistic target of rapamycin kinase	Homo sapiens	101-105
29228829-2	2018	The aim of the present study was to evaluate effects of vanadium pentoxide (V2O5) on other IL-2 receptor-mediated signaling pathways, i.e. PI3K-AKT-mTOR and Ras-MAPK.	vanadium pentoxide	56-74	interleukin 2	Homo sapiens	91-95
29228829-2	2018	The aim of the present study was to evaluate effects of vanadium pentoxide (V2O5) on other IL-2 receptor-mediated signaling pathways, i.e. PI3K-AKT-mTOR and Ras-MAPK.	vanadium pentoxide	56-74	AKT serine/threonine kinase 1	Homo sapiens	144-147
29228829-2	2018	The aim of the present study was to evaluate effects of vanadium pentoxide (V2O5) on other IL-2 receptor-mediated signaling pathways, i.e. PI3K-AKT-mTOR and Ras-MAPK.	vanadium pentoxide	76-80	interleukin 2	Homo sapiens	91-95
29228829-12	2018	PTEN expression increased significantly at 100 muM V2O5 exposure whereas pPTEN decreased by 18% at 25 muM V2O5 concentrations, but remained unchanged thereafter.	vanadium pentoxide	51-55	phosphatase and tensin homolog	Homo sapiens	0-4
29228829-14	2018	These results indicated a toxic effect of V2O5 on NK cells that was due in part to dysregulation of signaling pathways mediated by IL-2 via increased PTEN and decreased SHP1 expression.	vanadium pentoxide	42-46	interleukin 2	Homo sapiens	131-135
29228829-14	2018	These results indicated a toxic effect of V2O5 on NK cells that was due in part to dysregulation of signaling pathways mediated by IL-2 via increased PTEN and decreased SHP1 expression.	vanadium pentoxide	42-46	phosphatase and tensin homolog	Homo sapiens	150-154
29228829-14	2018	These results indicated a toxic effect of V2O5 on NK cells that was due in part to dysregulation of signaling pathways mediated by IL-2 via increased PTEN and decreased SHP1 expression.	vanadium pentoxide	42-46	nuclear receptor subfamily 0 group B member 2	Homo sapiens	169-173
27936662-5	2017	The strong electron-phonon coupling of the vanadia particles has been proposed to create the O - radicals (V5+ = O2-+ heat   V4+-O -) for the n > 25 clusters with Delta = -2, -1, 0, and 2.	vanadium pentoxide	43-50	delta like non-canonical Notch ligand 1	Homo sapiens	166-190
29532885-0	2018	Induction of Th1 chemokine secretion in dermal fibroblasts by vanadium pentoxide.	vanadium pentoxide	62-80	negative elongation factor complex member C/D	Homo sapiens	13-16
28731738-0	2017	Spin-Orbital Correlated Dynamics in the Spinel-Type Vanadium Oxide MnV_{2}O_{4}.	vanadium pentoxide	52-66	spindlin 1	Homo sapiens	0-4
30096759-2	2018	We have proposed three kinds of L-type 2-leg and 4-leg with the pixel pitch of 35 mum based on vanadium oxide absorbent membrane sandwiched with top passivated and bottom Si3N4 supporting films, respectively.	vanadium pentoxide	95-109	ribosomal protein L4	Homo sapiens	32-50
29901202-0	2018	CXCL8 and CXCL11 chemokine secretion in dermal fibroblasts is differentially modulated by vanadium pentoxide.	vanadium pentoxide	90-108	C-X-C motif chemokine ligand 8	Homo sapiens	0-5
29901202-0	2018	CXCL8 and CXCL11 chemokine secretion in dermal fibroblasts is differentially modulated by vanadium pentoxide.	vanadium pentoxide	90-108	C-X-C motif chemokine ligand 11	Homo sapiens	10-16
29568907-0	2018	Differential modulation by vanadium pentoxide of the secretion of CXCL8 and CXCL11 chemokines in thyroid cells.	vanadium pentoxide	27-45	C-X-C motif chemokine ligand 8	Homo sapiens	66-71
29568907-0	2018	Differential modulation by vanadium pentoxide of the secretion of CXCL8 and CXCL11 chemokines in thyroid cells.	vanadium pentoxide	27-45	C-X-C motif chemokine ligand 11	Homo sapiens	76-82
29517108-0	2018	Vanadium pentoxide induces the secretion of CXCL9 and CXCL10 chemokines in thyroid cells.	vanadium pentoxide	0-18	C-X-C motif chemokine ligand 9	Homo sapiens	44-49
29517108-0	2018	Vanadium pentoxide induces the secretion of CXCL9 and CXCL10 chemokines in thyroid cells.	vanadium pentoxide	0-18	C-X-C motif chemokine ligand 10	Homo sapiens	54-60
29489387-4	2018	This observation, along with those of recent studies of iron oxide, vanadium pentoxide, and molybdenum trioxide nanoparticles that behave as mimics of peroxidase, bromoperoxidase, and sulfite oxidase, respectively, indicates that the oxo-metal bond in the oxide nanoparticles is critical for the function of these corresponding natural metalloproteins.	vanadium pentoxide	68-86	sulfite oxidase	Homo sapiens	163-199
28732164-3	2017	Interlayer water in V2O5 and MnO2 has been shown to improve Mg2+ intercalation kinetics in nonaqueous electrolytes.	vanadium pentoxide	20-24	mucin 7, secreted	Homo sapiens	60-63
27523255-2	2016	In this work, novel copper-containing MOR-type zeolites Cu-MOR were synthesized in a one-pot template-free route and served as efficient supports for vanadium oxide.	vanadium pentoxide	150-164	opioid receptor mu 1	Homo sapiens	38-41
27523255-2	2016	In this work, novel copper-containing MOR-type zeolites Cu-MOR were synthesized in a one-pot template-free route and served as efficient supports for vanadium oxide.	vanadium pentoxide	150-164	opioid receptor mu 1	Homo sapiens	59-62
26562331-0	2016	Ultrasensitive non-enzymatic immunosensor for carcino-embryonic antigen based on palladium hybrid vanadium pentoxide/multiwalled carbon nanotubes.	vanadium pentoxide	98-116	CEA cell adhesion molecule 3	Homo sapiens	46-71
25565016-0	2016	Vanadium pentoxide prevents NK-92MI cell proliferation and IFNgamma secretion through sustained JAK3 phosphorylation.	vanadium pentoxide	0-18	interferon gamma	Homo sapiens	59-67
26749240-7	2016	When used as a cathode material for lithium-ion batteries, the V2O5 hollow spheres display a diameter-dependent electrochemical performance, and the 440 nm hollow spheres show the highest specific discharge capacity of 377.5 mAhg(-1) at a current density of 50 mAg(-1) , and are better than the corresponding solid spheres and nanorod assemblies.	vanadium pentoxide	63-67	dentin matrix protein 1	Mus musculus	261-267
25565016-0	2016	Vanadium pentoxide prevents NK-92MI cell proliferation and IFNgamma secretion through sustained JAK3 phosphorylation.	vanadium pentoxide	0-18	Janus kinase 3	Homo sapiens	96-100
26344174-3	2015	In this work, the rapid and controllable spin-spray layer-by-layer (SSLbL) method is used to generate high quality networks of 1D nanomaterials: single-walled carbon nanotubes (SWNT) and vanadium pentoxide (V2O5) nanowires for anode and cathode electrodes, respectively.	vanadium pentoxide	187-205	spindlin 1	Homo sapiens	41-45
26344174-3	2015	In this work, the rapid and controllable spin-spray layer-by-layer (SSLbL) method is used to generate high quality networks of 1D nanomaterials: single-walled carbon nanotubes (SWNT) and vanadium pentoxide (V2O5) nanowires for anode and cathode electrodes, respectively.	vanadium pentoxide	207-211	spindlin 1	Homo sapiens	41-45
26232257-6	2015	Previously, K-ras mutations have been detected in the lung tumors in mice exposed to V2O5.	vanadium pentoxide	85-89	Kirsten rat sarcoma viral oncogene homolog	Mus musculus	12-17
26232258-0	2015	Quantification of Kras mutant fraction in the lung DNA of mice exposed to aerosolized particulate vanadium pentoxide by inhalation.	vanadium pentoxide	98-116	Kirsten rat sarcoma viral oncogene homolog	Mus musculus	18-22
26232258-1	2015	This study investigated whether Kras mutation is an early event in the development of lung tumors induced by inhalation of particulate vanadium pentoxide (VP) aerosols.	vanadium pentoxide	135-153	Kirsten rat sarcoma viral oncogene homolog	Mus musculus	32-36
26232258-1	2015	This study investigated whether Kras mutation is an early event in the development of lung tumors induced by inhalation of particulate vanadium pentoxide (VP) aerosols.	vanadium pentoxide	155-157	Kirsten rat sarcoma viral oncogene homolog	Mus musculus	32-36
22693688-14	2012	Vanadium pentoxide causes expression of COX-2 and the release of proinflammatory cytokines in a human lung fibroblast model.	vanadium pentoxide	0-18	mitochondrially encoded cytochrome c oxidase II	Homo sapiens	40-45
25296879-8	2014	Surprisingly, the carcinogenic potential of vanadium oxide NPs came into light which was indicated by terminal deoxynucleotidyl transferase dUTP nick-end labeling assay as well as the decreased levels of p53 and Bax, in lung tissue of NP-exposed animals.	vanadium pentoxide	44-58	Wistar clone pR53P1 p53 pseudogene	Rattus norvegicus	204-207
25296879-8	2014	Surprisingly, the carcinogenic potential of vanadium oxide NPs came into light which was indicated by terminal deoxynucleotidyl transferase dUTP nick-end labeling assay as well as the decreased levels of p53 and Bax, in lung tissue of NP-exposed animals.	vanadium pentoxide	44-58	BCL2 associated X, apoptosis regulator	Rattus norvegicus	212-215
25079002-1	2014	Uniform amorphous vanadium oxide films were coated on graphene via atomic layer deposition and the nano-composite displays an exceptional capacity of ~900 mA h g(-1) at 200 mAg(-1) with an excellent capacity retention at 1 A g(-1) after 200 cycles.	vanadium pentoxide	18-32	dentin matrix protein 1	Mus musculus	173-179
24738373-1	2014	We used a hydrothermal method to synthesis the solution-processed V2O5 as anode buffer layer, which applied on inverted polymer solar cells based on FTO substrate.	vanadium pentoxide	66-70	FTO alpha-ketoglutarate dependent dioxygenase	Homo sapiens	149-152
24407677-7	2014	It demonstrated much higher photocatalytic efficiency of photodegradation of organic dyes compared with the pure CNF and vanadium oxide embedded CNF (V-CNF).	vanadium pentoxide	121-135	NPHS1 adhesion molecule, nephrin	Homo sapiens	145-148
24407677-7	2014	It demonstrated much higher photocatalytic efficiency of photodegradation of organic dyes compared with the pure CNF and vanadium oxide embedded CNF (V-CNF).	vanadium pentoxide	121-135	NPHS1 adhesion molecule, nephrin	Homo sapiens	150-155
22512508-5	2012	This paper reports a decrease in the presence of the CD11c surface marker on mouse thymic dendritic cells (DC) as a result of host exposure to vanadium (here, in the form of vanadium pentoxide; V(2)O(5)) over a period of 4 weeks.	vanadium pentoxide	174-192	integrin alpha X	Mus musculus	53-58
24362016-5	2014	Recently, we demonstrated that V2O5 induces dopaminergic neurotoxicity via protein kinase C delta (PKCdelta)-dependent oxidative signaling mechanisms in dopaminergic neuronal cells.	vanadium pentoxide	31-35	protein kinase C, delta	Mus musculus	75-97
24362016-5	2014	Recently, we demonstrated that V2O5 induces dopaminergic neurotoxicity via protein kinase C delta (PKCdelta)-dependent oxidative signaling mechanisms in dopaminergic neuronal cells.	vanadium pentoxide	31-35	protein kinase C, delta	Mus musculus	99-107
23041724-0	2012	The local environment of Co2+ ions intercalated in vanadium oxide/hexadecylamine nanotubes.	vanadium pentoxide	51-65	complement C2	Homo sapiens	25-28
19597706-4	2009	Our results show that 2.0 mM vanadium pentoxide in culture medium induced a significant increase of malonaldehyde level and Glutathione peroxidase activity, a slightly increase of Catalase A activity as well as a decrease of wet weight and mitochondrial NADH cit c reductase of S. cerevisiae UE-ME(3).	vanadium pentoxide	29-47	catalase A	Saccharomyces cerevisiae S288C	180-190
20831213-6	2010	Different from vanadium oxide, the conductance of a single Si/a-Si core/shell nanowire monotonously decreased along with the electrochemical test, which agrees with Raman mapping of single Si/a-Si nanowire at different charge/discharge states, indicating permanent structure change after lithium ion insertion and extraction.	vanadium pentoxide	15-29	arylsulfatase family member I	Homo sapiens	62-66
19646462-11	2009	Furthermore, PKCdelta knockdown using siRNA protected N27 cells from V2O5-induced apoptotic cell death.	vanadium pentoxide	69-73	protein kinase C delta	Homo sapiens	13-21
17961495-4	2007	In this present study, we investigated that exposure of human bronchial epithelial cells (Beas-2B) to vanadium pentoxide resulted in an obvious induction of cyclooxygenase-2 (COX-2) expression and this induction was both dose- and time-dependent.	vanadium pentoxide	102-120	prostaglandin-endoperoxide synthase 2	Homo sapiens	157-173
19705911-1	2009	Double-shelled nanocapsules of V(2)O(5)-SnO(2) composites were chemically assembled via a one-pot solution method.	vanadium pentoxide	31-39	strawberry notch homolog 1	Homo sapiens	40-43
18322232-0	2008	STAT-1 signaling in human lung fibroblasts is induced by vanadium pentoxide through an IFN-beta autocrine loop.	vanadium pentoxide	57-75	signal transducer and activator of transcription 1	Homo sapiens	0-6
18322232-0	2008	STAT-1 signaling in human lung fibroblasts is induced by vanadium pentoxide through an IFN-beta autocrine loop.	vanadium pentoxide	57-75	interferon beta 1	Homo sapiens	87-95
18322232-5	2008	We also reported that V(2)O(5)-induced STAT-1 phosphorylation in lung fibroblasts requires H(2)O(2) and de novo protein synthesis.	vanadium pentoxide	22-30	signal transducer and activator of transcription 1	Homo sapiens	39-45
17961495-6	2007	Furthermore, we found that inhibition of NFAT by dominant negative mutant of NFAT (DN-NFAT) resulted in a dramatic inhibition of COX-2 expression induced by vanadium pentoxide, showing that NFAT activation was required for COX-2 induction by vanadium pentoxide in Beas-2B cells.	vanadium pentoxide	157-175	prostaglandin-endoperoxide synthase 2	Homo sapiens	129-134
17961495-6	2007	Furthermore, we found that inhibition of NFAT by dominant negative mutant of NFAT (DN-NFAT) resulted in a dramatic inhibition of COX-2 expression induced by vanadium pentoxide, showing that NFAT activation was required for COX-2 induction by vanadium pentoxide in Beas-2B cells.	vanadium pentoxide	157-175	prostaglandin-endoperoxide synthase 2	Homo sapiens	223-228
17961495-6	2007	Furthermore, we found that inhibition of NFAT by dominant negative mutant of NFAT (DN-NFAT) resulted in a dramatic inhibition of COX-2 expression induced by vanadium pentoxide, showing that NFAT activation was required for COX-2 induction by vanadium pentoxide in Beas-2B cells.	vanadium pentoxide	242-260	prostaglandin-endoperoxide synthase 2	Homo sapiens	129-134
17961495-6	2007	Furthermore, we found that inhibition of NFAT by dominant negative mutant of NFAT (DN-NFAT) resulted in a dramatic inhibition of COX-2 expression induced by vanadium pentoxide, showing that NFAT activation was required for COX-2 induction by vanadium pentoxide in Beas-2B cells.	vanadium pentoxide	242-260	prostaglandin-endoperoxide synthase 2	Homo sapiens	223-228
17961495-8	2007	Together, our results demonstrated that COX-2 expression could be induced by vanadium pentoxide in NFAT-dependent way and played an anti-apoptotic role in Beas-2B cells.	vanadium pentoxide	77-95	prostaglandin-endoperoxide synthase 2	Homo sapiens	40-45
17961495-4	2007	In this present study, we investigated that exposure of human bronchial epithelial cells (Beas-2B) to vanadium pentoxide resulted in an obvious induction of cyclooxygenase-2 (COX-2) expression and this induction was both dose- and time-dependent.	vanadium pentoxide	102-120	prostaglandin-endoperoxide synthase 2	Homo sapiens	175-180
17265967-6	2007	Vanadium oxide leads to an induction of heme oxygenase 1 (HO-1) in a dose dependent manner in ECV304 cells whereas a reduction in protein levels can be observed for the epithelial cells (A549).	vanadium pentoxide	0-14	heme oxygenase 1	Homo sapiens	40-56
17269701-8	2007	However, the use of conductive vanadia-silica gels with encapsulated GDH resulted in complete conversion of alpha-ketoglutarate to l-glutamate.	vanadium pentoxide	31-38	glutamate dehydrogenase 1	Homo sapiens	69-72
17265967-6	2007	Vanadium oxide leads to an induction of heme oxygenase 1 (HO-1) in a dose dependent manner in ECV304 cells whereas a reduction in protein levels can be observed for the epithelial cells (A549).	vanadium pentoxide	0-14	heme oxygenase 1	Homo sapiens	58-62
16684564-3	2006	Reports about V inhalation toxicity on the CNS are limited, thus the purpose of this study is to determine the effects of Vanadium pentoxide (V(2)O(5)) inhalation (0.02M) on the memory and its correlation with the cytology of the hippocampus CA1.	vanadium pentoxide	122-140	carbonic anhydrase 1	Mus musculus	242-245